Exact Mass: 462.2326
Exact Mass Matches: 462.2326
Found 373 metabolites which its exact mass value is equals to given mass value 462.2326
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
ST 25:5;O8
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents Same as: D01442 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-Dehydrotestosterone glucuronide
6-Dehydrotestosterone glucuronide is a natural human metabolite of 6-dehydrotestosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
hydrocortisone hemisuccinate
Sar-Pro-Arg-pNA
SCHEMBL13960539
7-Acetoxybonducellpin C
(2RS,3SR)-3,4-dihydro-7-(6-hydroxybenzofuran-2-yl)-2-methyl-6-(3-methylbut-2-enyl)-2-(4-methylpent-3-enyl)-2H-1-benzopyran-3,5-diol|artopetelin F
8-O-(2-methylbutyryl)-dimerostemmolide-1-(5-hydroxyangelate)|8-O-<2-methylbutyryl>-dimerostemmolide-1-<5-hydroxyangelate>
(2R)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-5,7-bis(3-methylbut-2-en-1-yl)-2,4-bi-1-benzofuran-6,6-diol|artonitidin A
16alpha-Acetoxy-19-O-acetyl-15-oxo-15,16-diydrohautriwasaeure-methylester
artocarpol I|rel-(17R,18R)-3,4-dihydro-2-methyl-6-(3-methylbut-2-enyl)-2-(4-methylpent-3-enyl)-2H-dibenzo[b.f]pyrano[2,3-d]oxepine-3alpha,7,11-triol
3beta,6beta-diangeloyloxy-8beta,10beta-dihydroxyeremophilenolide
claviridin C|methyl (4S,5Z,7E,12b,14Z,16R)-4,12-bis(acetyloxy)-16-hydroxy-9-oxoprosta-5,7,10,14-tetraen-1-oate
3beta-(2-methylbutanoyloxy)-8-beta-(2R,3R)-epoxyangeloyloxy-leptocarpin
1beta,8beta-dihydroxy-2beta,3alpha-diangeloyloxyeremophil-7(11)-en-8alpha(12)-olide
6Alpha,21-diacetoxy-11beta,17alpha-dihydroxypregn-4-ene-3,20-dione
7-O-deacetoxy-3-O-acetoxybonducellpin C|caesalpinin MF
2-[2-(3,3-dimethyloxiran-2-yl)ethyl]-3,4-dihydro-6-(3-methylbut-2-enyl)-2H-dibenzo[b,f]pyrano[2,3-d]oxepin-7,11-diol|artocarpol G
1,7-dihydroxy-3-methoxy-2-isoprenyl-4-geranylxanthone|pruniflorone L
Hydrocortisone hemisuccinate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
methyl 4,10-diacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate
C25H34O8_beta-D-Glucopyranoside, 5-(4-hydroxyphenyl)-1-[2-(4-hydroxyphenyl)ethyl]pentyl
C25H34O8_1H-Furo[3,4-b]xanthene-9-propanoic acid, 3,5a,6,7,8,9,9a,10-octahydro-7-hydroxy-8-(1-hydroxy-1-methylethyl)-11-methoxy-4,5a,9-trimethyl-1-oxo-, (5aS,9R,9aR)
C25H34O8_1H-Furo[3,4-b]xanthene-9-propanoic acid, 3,5a,6,7,8,9,9a,10-octahydro-7-hydroxy-8-(1-hydroxy-1-methylethyl)-11-methoxy-4,5a,9-trimethyl-1-oxo
3-[7-hydroxy-8-(2-hydroxypropan-2-yl)-11-methoxy-4,5a,9-trimethyl-1-oxo-3,6,7,8,9a,10-hexahydro-[2]benzofuro[5,6-b]chromen-9-yl]propanoic acid
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 4,10-diacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
3-[7-hydroxy-8-(2-hydroxypropan-2-yl)-11-methoxy-4,5a,9-trimethyl-1-oxo-3,6,7,8,9a,10-hexahydro-[2]benzofuro[5,6-b]chromen-9-yl]propanoic acid_major
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_minor
methyl 4,10-diacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate_major
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_78.3\\%
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_80.4\\%
Ala His His Val
Ala His Val His
Ala Lys Met Asn
Ala Lys Asn Met
Ala Met Lys Asn
Ala Met Asn Lys
Ala Asn Lys Met
Ala Asn Met Lys
Ala Val His His
Cys Gly Lys Arg
Cys Gly Arg Lys
Cys Lys Gly Arg
Cys Lys Asn Val
Cys Lys Arg Gly
Cys Lys Val Asn
Cys Asn Lys Val
Cys Asn Val Lys
Cys Arg Gly Lys
Cys Arg Lys Gly
Cys Val Lys Asn
Cys Val Asn Lys
Glu Ile Thr Thr
Glu Leu Thr Thr
Glu Thr Ile Thr
Glu Thr Leu Thr
Glu Thr Thr Ile
Glu Thr Thr Leu
Gly Cys Lys Arg
Gly Cys Arg Lys
Gly His His Ile
Gly His His Leu
Gly His Ile His
Gly His Leu His
Gly Ile His His
Gly Lys Cys Arg
Gly Lys Met Gln
Gly Lys Gln Met
Gly Lys Arg Cys
Gly Leu His His
Gly Met Lys Gln
Gly Met Gln Lys
Gly Gln Lys Met
Gly Gln Met Lys
Gly Arg Cys Lys
Gly Arg Lys Cys
His Ala His Val
His Ala Val His
His Gly His Ile
His Gly His Leu
His Gly Ile His
His Gly Leu His
His His Ala Val
His His Gly Ile
His His Gly Leu
His His Ile Gly
His His Leu Gly
His His Val Ala
His Ile Gly His
His Ile His Gly
His Leu Gly His
His Leu His Gly
His Val Ala His
His Val His Ala
Ile Glu Thr Thr
Ile Gly His His
Ile His Gly His
Ile His His Gly
Ile Thr Glu Thr
Ile Thr Thr Glu
Lys Ala Met Asn
Lys Ala Asn Met
Lys Cys Gly Arg
Lys Cys Asn Val
Lys Cys Arg Gly
Lys Cys Val Asn
Lys Gly Cys Arg
Lys Gly Met Gln
Lys Gly Gln Met
Lys Gly Arg Cys
Lys Met Ala Asn
Lys Met Gly Gln
Lys Met Asn Ala
Lys Met Gln Gly
Lys Asn Ala Met
Lys Asn Cys Val
Lys Asn Met Ala
Lys Asn Val Cys
Lys Gln Gly Met
Lys Gln Met Gly
Lys Arg Cys Gly
Lys Arg Gly Cys
Lys Val Cys Asn
Lys Val Asn Cys
Leu Glu Thr Thr
Leu Gly His His
Leu His Gly His
Leu His His Gly
Leu Thr Glu Thr
Leu Thr Thr Glu
Met Ala Lys Asn
Met Ala Asn Lys
Met Gly Lys Gln
Met Gly Gln Lys
Met Lys Ala Asn
Met Lys Gly Gln
Met Lys Asn Ala
Met Lys Gln Gly
Met Asn Ala Lys
Met Asn Lys Ala
Met Gln Gly Lys
Met Gln Lys Gly
Asn Ala Lys Met
Asn Ala Met Lys
Asn Cys Lys Val
Asn Cys Val Lys
Asn Lys Ala Met
Asn Lys Cys Val
Asn Lys Met Ala
Asn Lys Val Cys
Asn Met Ala Lys
Asn Met Lys Ala
Asn Val Cys Lys
Asn Val Lys Cys
Gln Gly Lys Met
Gln Gly Met Lys
Gln Lys Gly Met
Gln Lys Met Gly
Gln Met Gly Lys
Gln Met Lys Gly
Arg Cys Gly Lys
Arg Cys Lys Gly
Arg Gly Cys Lys
Arg Gly Lys Cys
Arg Lys Cys Gly
Arg Lys Gly Cys
Thr Glu Ile Thr
Thr Glu Leu Thr
Thr Glu Thr Ile
Thr Glu Thr Leu
Thr Ile Glu Thr
Thr Ile Thr Glu
Thr Leu Glu Thr
Thr Leu Thr Glu
Thr Thr Glu Ile
Thr Thr Glu Leu
Thr Thr Ile Glu
Thr Thr Leu Glu
Val Ala His His
Val Cys Lys Asn
Val Cys Asn Lys
Val His Ala His
Val His His Ala
Val Lys Cys Asn
Val Lys Asn Cys
Val Asn Cys Lys
Val Asn Lys Cys
6-dehydrotestosterone O-glucuronide
Methyl 1,6-diacetoxy-7,11-dihydroxyabieta-8,11,13-trien-18-oate
Vistusertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes. Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes.
Amelometasone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
5-[3-(3,5-Dimethyl-1,2,4-triazol-1-yl)-2-hydroxypropoxy]-2-methyl-1-(phenylmethyl)-3-indolecarboxylic acid ethyl ester
(1S,3S,5R,5aS,6S,7R,7S,9aR,10S,11S)-5a-(hydroxymethyl)-1,1,5,6,7,10-hexamethylspiro[2,9,12,13-tetraoxatetracyclo[8.2.1.01,5.07,11]tridecane-3,6-7,8,9,9a-tetrahydro-2-benzoxepine]-3,8-dione
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate
Arg-Lys-Cys-Gly
A tetrapeptide composed of L-arginine, L-lysine, L-cysteine, and glycine joined in sequence by peptide linkages.
(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-N,11-N-dimethyl-6-oxo-12-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-N,11-N-dimethyl-6-oxo-12-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
(1S)-2-benzoyl-1-(hydroxymethyl)-7-methoxy-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-2-benzoyl-1-(hydroxymethyl)-7-methoxy-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
2,3-dihydroxypropyl [3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-hydroxypropyl] hydrogen phosphate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-)
A docosanoid anion obtained by deprotonation of the two carboxy groups and protonation of the glutamyl alpha-amino group of (13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid; major species at pH 7.3.
methyl 1,6-bis(acetyloxy)-4a-hydroxy-4,4,11b-trimethyl-1h,2h,3h,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-7-carboxylate
2-[7-hydroxy-2,2-dimethyl-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-5-yl]-7-(3-methylbut-3-en-2-yl)-1-benzofuran-4,6-diol
(3as,4s,5s,5ar,6r,9s,9as,9br)-6,9-dihydroxy-5a,9-dimethyl-5-{[(2e)-2-methylbut-2-enoyl]oxy}-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl (2e)-2-methylbut-2-enoate
2-[3,5-dihydroxy-2,6-bis(3-methylbut-2-en-1-yl)phenyl]-7-[(2r)-3-methylbut-3-en-2-yl]-1-benzofuran-4,6-diol
5,17-dihydroxy-6,14,18-trimethyl-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-8-yl 2-methylbutanoate
(1s,4e,9s,10s,11z,14r)-9-hydroxy-15-isopropyl-16-methoxy-1,4,11-trimethyl-7,17-dioxo-6,18-dioxatricyclo[12.4.0.0⁵,⁹]octadeca-4,11,15-trien-10-yl acetate
(1r,4s,5r,9s,10r,13r,14s,16s,19s,21s,23s,24s)-7-isopropyl-10,13-dimethyl-15,17,20,22-tetraoxaheptacyclo[12.10.0.0²,²¹.0⁵,¹³.0⁶,¹⁰.0¹⁶,²⁴.0¹⁹,²³]tetracosa-2,6-diene-4,9,23,24-tetrol
(1s,2r,3r,4s,5s,6s)-2,3,5-trihydroxy-4,6-dimethoxycyclohexyl 2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromene-6-carboxylate
4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,7-dihydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)xanthen-9-one
7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-[(2r)-6-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-4-yl]-1-benzofuran-6-ol
16β-acetoxystrophanthidin
{"Ingredient_id": "HBIN001821","Ingredient_name": "16\u03b2-acetoxystrophanthidin","Alias": "NA","Ingredient_formula": "C25H34O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "281","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-acetoxybonducellpin c
{"Ingredient_id": "HBIN013020","Ingredient_name": "7-acetoxybonducellpin c","Alias": "NA","Ingredient_formula": "C25H34O8","Ingredient_Smile": "CC(=O)OC1CCC(C2(C1(C3CC4=C(C=CO4)C(C3C(C2)OC(=O)C)C(=O)OC)C)O)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "137","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}